TGA Approval

TASIGNA nilotinib 150 mg capsule blister pack (171498)

ARTG ID

171498

ARTG Name

TASIGNA nilotinib 150 mg capsule blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

September 5, 2011

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-CMI-00293-3

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00292-3

Ingredient Name

nilotinib hydrochloride monohydrate

Empowering clinical research with data-driven insights and AI-powered tools.

TASIGNA nilotinib 150 mg capsule blister pack (171498) - TGA 批准文号 | MedPath